USA, FDA’s launch of purple book, an online database for biologics

The US Food and Drug Administration launched the first version of the Purple Book, which is a searchable online database of biological product information.

The Purple Book will be updated weekly with newly approved biosimilar or interchangeable products, and their respective references being included within 10 working days. All functionality and all BLAs are expected to be available from August 2020.

Once the database is completed, it will allow easier searches to be made and offer information about all licensed biological products, including information ranging from product names, exclusivity, biologics license application submissions.